TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy.

Arch Endocrinol Metab · 2018 · PMC10118993 · PMID 29768627

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significancep = 0.14not close (p > 0.1)

The GO subgroup was younger than the subgroup without orbitopathy, but this diffenrence did not reach statistical significance (52.6 ± 12.3 years vs. 58.5 ± 11.9 years, p = 0.14).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.